NEW ROAD THERAPEUTICS LIMITEDActive

Company number 13664496Private limited companyIncorporated 2021

Key figures

−£5,527-114.1%
Net assets 2024/25
-7.5 k-5 k-2.5 k02.5 k5 k2021/222022/232023/242024/25

Like most small UK companies, NEW ROAD THERAPEUTICS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 k10 k2021/222022/232023/242024/25
Filed accounts2021/22–2024/25
2021/222022/232023/242024/25
Cash at bank and in hand7,4914,0022,045310
Total assets8,4074,5232,463578
Total liabilities5,2484,9855,0456,105
Net assets / total equity2,930-592-2,582-5,527
Average number of employees0000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

Research and experimental development on biotechnology

As described in the company's latest filed accounts.

Summary: NEW ROAD THERAPEUTICS LIMITED

Company

NEW ROAD THERAPEUTICS LIMITED is a private limited company registered with Companies House under company number 13664496. It was incorporated on 6 Oct 2021. Its status is active. The registered office is in Cambridge (CB1). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files small company accounts (filleted). Net assets were −£5,527, down 114.1% on the previous year. Cash at bank and in hand was £310. Total assets were £578 and total liabilities £6,105. The company had an average of 0 employees. Figures are available for 4 financial years (2021/22–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 27 Oct 2026.